Google Scholar: cites
Cocoa, Hazelnuts, Sterols and Soluble Fiber Cream Reduces Lipids and Inflammation Biomarkers in Hypertensive Patients : A Randomized Controlled Trial
Solà, Rosa (Universitat Rovira i Virgili)
Valls, Rosa M. (Universitat Rovira i Virgili)
Godàs, Gemma (Universitat Rovira i Virgili)
Perez-Busquets, Gloria (Universitat Rovira i Virgili)
Ribalta, Josep (Universitat Rovira i Virgili)
Girona, Josefa (Universitat Rovira i Virgili)
Heras, Mercedes (Universitat Rovira i Virgili)
Cabré Llobet, Anna (Universitat Rovira i Virgili)
Castro, Antoni (Universitat Rovira i Virgili)
Domenech, Gema (Universitat Autònoma de Barcelona)
Torres, Ferran (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública)
Masana, Luis (Universitat Rovira i Virgili)
Anglés, Neus (La Morella Nuts, Castellvell del Camp, Spain)
Reguant, Jordi (La Morella Nuts, Castellvell del Camp, Spain)
Ramírez, Bartolomé (La Morella Nuts, Castellvell del Camp, Spain)
Barriach, Joaquim M. (La Morella Nuts, Castellvell del Camp, Spain)

Data: 2012
Descripció: 7
Resum: Cocoa, mixed with other food ingredients, intake can have beneficial effects on cardiovascular disease (CVD) biomarkers. We compared the effects of 4 cocoa cream products on some of these biomarkers. In this multi-centered, randomized, controlled, double-blind, parallel trial, volunteers (n = 113; age range: 43-65 years) who were pre-hypertensive, stage-1 hypertensive and hypercholesterolemic received one of 4 cocoa cream products (13 g/unit; 1 g cocoa/unit, 6 units/d; 465 Kcal/d) added to a low saturated fat diet for 4 weeks. The groups were: A) (n = 28), cocoa cream considered as control; B) (n = 28), cocoa+hazelnut cream (30 g/d hazelnuts); C) (n = 30), cocoa+hazelnuts+phytosterols (2 g/d); and D) (n = 27), cocoa+hazelnuts+phytosterols+soluble fiber (20 g/d) the patented "LMN product". Primary outcome measures were BP, LDL-c, apolipoprotein B-100 (Apo B), ApoB/ApoA ratio, oxidized LDL (oxLDL) and high-sensitive C-reactive protein (hsCRP) determined at baseline and post-cocoa cream product intake. Statistical analysis used was ANCOVA or mixed models (in case of repeated measurements), with baseline observation included as a covariate. After 4 weeks, compared to product A, product C reduced LDL-c by 11. 2%, Apo B by 8. 1% and ApoB/ApoA ratio by 7. 8% (P = 0. 01). LMN decreased LDL-c by 9. 2%, Apo B-100 by 8. 5%, ApoB/ApoA ratio by 10. 5%, hsCRP by 33. 4% and oxLDL by 5. 9% (P = 0. 01). Surprisingly, even "control" product A reduced systolic BP (-7. 89 mmHg; 95%CI: -11. 45 to -4. 3) and diastolic BP (-5. 54 mmHg; 95%CI: -7. 79 to -3. 29). The BP reductions were similar with the other 3 products. Limitations of the study are that the trial period was relatively short and that a better "BP control" product would have been preferable. The creams (particularly the LMN) have anti-inflammatory and antioxidant effects in addition to lowering LDL-c, Apo B and ApoB/ApoA ratio. Thus, the soluble fiber effects amplified with sterols (as contained in the cocoa creams) provide new dietary therapeutic perspectives.
Drets: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Llengua: Anglès
Document: Article ; recerca ; Versió publicada
Publicat a: PloS one, Vol. 7, Num. 2 (February 2012) , art. e31103, ISSN 1932-6203

DOI: 10.1371/journal.pone.0031103
PMID: 22383996


7 p, 188.1 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats

 Registre creat el 2025-10-24, darrera modificació el 2026-07-06



   Favorit i Compartir